Breaking old paradigms: Th17 cells in autoimmune arthritis.
暂无分享,去创建一个
[1] L. Wedderburn,et al. Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis. , 2009, Rheumatology.
[2] F. D’Acquisto,et al. Interleukin 17 sustains rather than induces inflammation. , 2009, Biochemical pharmacology.
[3] M. Rossol,et al. Cytokine-induced human IFN-gamma-secreting effector-memory Th cells in chronic autoimmune inflammation. , 2009, Blood.
[4] E. Podack,et al. APRIL (TNFSF13) regulates collagen‐induced arthritis, IL‐17 production and Th2 response , 2008, European journal of immunology.
[5] W. Nacken,et al. Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis. , 2008, Arthritis and rheumatism.
[6] M. Hashizume,et al. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. , 2008, Rheumatology.
[7] S. Alzabin,et al. Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells , 2008, The Journal of experimental medicine.
[8] J. Goldberg,et al. IL-17 Is a Critical Component of Vaccine-Induced Protection against Lung Infection by Lipopolysaccharide-Heterologous Strains of Pseudomonas aeruginosa1 , 2008, The Journal of Immunology.
[9] B. Zheng,et al. Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis , 2008, Proceedings of the National Academy of Sciences.
[10] B. Lim,et al. Retinoic Acid Increases Foxp3+ Regulatory T Cells and Inhibits Development of Th17 Cells by Enhancing TGF-β-Driven Smad3 Signaling and Inhibiting IL-6 and IL-23 Receptor Expression1 , 2008, The Journal of Immunology.
[11] T. Glant,et al. Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption. , 2008, Arthritis and rheumatism.
[12] L. Steinman. A rush to judgment on Th17 , 2008, The Journal of experimental medicine.
[13] D. Ganea,et al. In Vitro Differentiation of Dendritic Cells in the Presence of Prostaglandin E2 Alters the IL-12/IL-23 Balance and Promotes Differentiation of Th17 Cells1 , 2008, The Journal of Immunology.
[14] Y. Iwakura,et al. Development of Proteoglycan-Induced Arthritis Is Independent of IL-171 , 2008, The Journal of Immunology.
[15] S. Zheng,et al. Cutting Edge: Foxp3+CD4+CD25+ Regulatory T Cells Induced by IL-2 and TGF-β Are Resistant to Th17 Conversion by IL-61 , 2008, The Journal of Immunology.
[16] P. Baeuerle,et al. Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor α-independent mouse model , 2008, Annals of the rheumatic diseases.
[17] Tiina Laitala-Leinonen,et al. Osteoclast lineage and function. , 2008, Archives of biochemistry and biophysics.
[18] Jianping Jin,et al. Simvastatin Inhibits IL-17 Secretion by Targeting Multiple IL-17-Regulatory Cytokines and by Inhibiting the Expression of IL-17 Transcription Factor RORC in CD4+ Lymphocytes , 2008, The Journal of Immunology.
[19] H. Takayanagi,et al. The dynamic interplay between osteoclasts and the immune system. , 2008, Archives of biochemistry and biophysics.
[20] Sung-Hwan Park,et al. IL-17 induces the production of IL-16 in rheumatoid arthritis , 2008, Experimental & Molecular Medicine.
[21] J. Lord,et al. Prolonged, granulocyte–macrophage colony-stimulating factor-dependent, neutrophil survival following rheumatoid synovial fibroblast activation by IL-17 and TNFalpha , 2008, Arthritis research & therapy.
[22] S-Y Hwang,et al. Oral administration of type-II collagen suppresses IL-17-associated RANKL expression of CD4+ T cells in collagen-induced arthritis. , 2008, Immunology letters.
[23] Amita Aggarwal,et al. Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases. , 2008, The Journal of rheumatology.
[24] K. Paraskevas. Statin treatment for rheumatoid arthritis: a promising novel indication , 2008, Clinical Rheumatology.
[25] T. Miyazaki,et al. High concentration simvastatin induces apoptosis in fibroblast-like synoviocytes from patients with rheumatoid arthritis. , 2008, The Journal of rheumatology.
[26] Yuka Kanno,et al. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. , 2008, Blood.
[27] Chen Dong,et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. , 2008, Immunity.
[28] Y. Iwamoto,et al. Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis , 2007, Annals of the rheumatic diseases.
[29] T. Mcclanahan,et al. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell–mediated pathology , 2007, Nature Immunology.
[30] Hiromu Ito,et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model , 2007, The Journal of experimental medicine.
[31] N. Tsuno,et al. IL-17B and IL-17C Are Associated with TNF-α Production and Contribute to the Exacerbation of Inflammatory Arthritis1 , 2007, The Journal of Immunology.
[32] M. Gajda,et al. Exacerbation of Antigen-Induced Arthritis in IFN-γ-Deficient Mice As a Result of Unrestricted IL-17 Response1 , 2007, The Journal of Immunology.
[33] Kenji Chiba. IL-15, IL-17を標的とした新しい経口抗リウマチ薬の研究開発 , 2007 .
[34] N. Kamatani,et al. IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats , 2007, Arthritis research & therapy.
[35] P. Lazzerini,et al. Simvastatin inhibits cytokine production and nuclear factor-kB activation in interleukin 1beta-stimulated synoviocytes from rheumatoid arthritis patients. , 2007, Clinical and experimental rheumatology.
[36] D. Ganea,et al. Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis. , 2007, Arthritis and rheumatism.
[37] M. van Lookeren Campagne,et al. A novel inhibitor of the alternative pathway of complement reverses inflammation and bone destruction in experimental arthritis , 2007, The Journal of experimental medicine.
[38] Graham M Lord,et al. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease , 2007, Clinical and experimental immunology.
[39] K. Elkon,et al. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17. , 2007, Arthritis and rheumatism.
[40] Masaaki Takahashi,et al. Treatment with anti-TNF-α antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis , 2007, Clinical Rheumatology.
[41] Satoshi Tanaka,et al. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis , 2007, The Journal of experimental medicine.
[42] Y. Kadono,et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction , 2006, The Journal of experimental medicine.
[43] J. Thurman,et al. Alternative Complement Pathway Activation Is Essential for Inflammation and Joint Destruction in the Passive Transfer Model of Collagen-Induced Arthritis1 , 2006, The Journal of Immunology.
[44] Y. Okada,et al. Differential expression of WNTs and FRPs in the synovium of rheumatoid arthritis and osteoarthritis. , 2006, Biochemical and biophysical research communications.
[45] Q. Zhong,et al. IL-17 Receptor Knockout Mice Have Enhanced Myelotoxicity and Impaired Hemopoietic Recovery Following Gamma Irradiation , 2006, The Journal of Immunology.
[46] R. D. Hatton,et al. Transforming growth factor-β induces development of the TH17 lineage , 2006, Nature.
[47] A. Facchini,et al. Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts. , 2006, Osteoarthritis and cartilage.
[48] A. Amcheslavsky,et al. Interleukin (IL)‐12 mediates the anti‐osteoclastogenic activity of CpG‐oligodeoxynucleotides , 2006, Journal of cellular physiology.
[49] T. Miyazaki,et al. Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblast-like synoviocytes from patients with rheumatoid arthritis. , 2006, The Journal of rheumatology.
[50] K. Yudoh,et al. Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis. , 2006, Arthritis and rheumatism.
[51] J. H. Lee,et al. IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes , 2006, Clinical Rheumatology.
[52] N. Kamatani,et al. IFN‐γ‐producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL , 2005, European journal of immunology.
[53] L. Joosten,et al. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. , 2005, Arthritis and rheumatism.
[54] J. Pers,et al. BAFF Overexpression Is Associated with Autoantibody Production in Autoimmune Diseases , 2005, Annals of the New York Academy of Sciences.
[55] B. Troen,et al. RANK ligand and interferon gamma differentially regulate cathepsin gene expression in pre-osteoclastic cells. , 2005, Biochemical and biophysical research communications.
[56] F. Ruschitzka,et al. Simvastatin improves endothelial function in patients with rheumatoid arthritis. , 2005, Journal of the American College of Cardiology.
[57] C. Brinckerhoff,et al. Selective retinoic acid receptor ligands for rheumatoid arthritis. , 2004, Current opinion in investigational drugs.
[58] L. Stamp,et al. Upregulation of synoviocyte COX-2 through interactions with T lymphocytes: role of interleukin 17 and tumor necrosis factor-alpha. , 2004, The Journal of rheumatology.
[59] M. Lotze,et al. Interleukin-17 augments tumor necrosis factor-alpha-induced elaboration of proangiogenic factors from fibroblasts. , 2004, Immunology letters.
[60] W. Li,et al. Interleukin-17 signal transduction pathways implicated in inducing matrix metalloproteinase-3, -13 and aggrecanase-1 genes in articular chondrocytes. , 2004, Cellular signalling.
[61] Ju-Young Kim,et al. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-κB- and PI3-kinase/Akt-dependent pathways , 2004, Arthritis research & therapy.
[62] T. Mcclanahan,et al. Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation , 2003, The Journal of experimental medicine.
[63] S. Nakae,et al. Suppression of Immune Induction of Collagen-Induced Arthritis in IL-17-Deficient Mice 1 , 2003, The Journal of Immunology.
[64] Z. Song,et al. IFNγ deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vβ6 and Vβ8 in arthritic joints , 2003 .
[65] J. Lapointe,et al. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[66] S. Goldring,et al. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. , 2003, Rheumatology.
[67] L. Joosten,et al. IL-17 Promotes Bone Erosion in Murine Collagen-Induced Arthritis Through Loss of the Receptor Activator of NF-κB Ligand/Osteoprotegerin Balance 1 , 2003, The Journal of Immunology.
[68] J. Pelletier,et al. Interleukin 17, a nitric oxide-producing cytokine with a peroxynitrite-independent inhibitory effect on proteoglycan synthesis. , 2002, The Journal of rheumatology.
[69] E. Schwarz,et al. Exposure to receptor-activator of NFκB ligand renders pre-osteoclasts resistant to IFN-γ by inducing terminal differentiation , 2002, Arthritis research & therapy.
[70] M. Cutolo,et al. Synovial fluid from patients with rheumatoid arthritis inhibits neutrophil apoptosis: role of adenosine and proinflammatory cytokines. , 2002, Rheumatology.
[71] E. Filvaroff,et al. Interleukin 17 induced nitric oxide suppresses matrix synthesis and protects cartilage from matrix breakdown. , 2002, The Journal of rheumatology.
[72] A. Rowan,et al. Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines , 2002, Annals of the rheumatic diseases.
[73] A. Kehlen,et al. Expression, modulation and signalling of IL‐17 receptor in fibroblast‐like synoviocytes of patients with rheumatoid arthritis , 2002, Clinical and experimental immunology.
[74] T. Martin,et al. Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis , 2002 .
[75] M. Korabiowska,et al. Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's disease , 2001, Gut.
[76] K. Hillan,et al. Pathways by which interleukin 17 induces articular cartilage breakdown in vitro and in vivo. , 2001, Cytokine.
[77] W. B. van den Berg,et al. Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain. , 2001, Arthritis and rheumatism.
[78] J. Bijlsma,et al. Interleukin 10 (IL-10), not IL-4 or interferon-gamma production, correlates with progression of joint destruction in rheumatoid arthritis. , 2001, The Journal of rheumatology.
[79] L. Joosten,et al. IL-1-Independent Role of IL-17 in Synovial Inflammation and Joint Destruction During Collagen-Induced Arthritis1 , 2001, The Journal of Immunology.
[80] M. Leach,et al. Ubiquitous Transgenic Expression of the IL-23 Subunit p19 Induces Multiorgan Inflammation, Runting, Infertility, and Premature Death , 2001, The Journal of Immunology.
[81] Y. Sugimoto,et al. Regulation of TNFalpha and interleukin-10 production by prostaglandins I(2) and E(2): studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists. , 2001, Biochemical pharmacology.
[82] N. Kamatani,et al. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. , 2001, Arthritis and rheumatism.
[83] C. Löwik,et al. Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: is there dependency on nuclear factor-kappaB and receptor activator of nuclear factor kappaB (RANK)/RANK ligand signaling? , 2001, Bone.
[84] L. Joosten,et al. IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis , 2001, Arthritis research.
[85] S. Hsieh,et al. Enhanced Secretion of IFN-γ by Activated Th1 Cells Occurs Via Reverse Signaling Through TNF-Related Activation-Induced Cytokine1 , 2001, The Journal of Immunology.
[86] A. Hoffmann,et al. Regulation of IL-6 and IL-8 Expression in Rheumatoid Arthritis Synovial Fibroblasts: the Dominant Role for NF-κB But Not C/EBPβ or c-Jun1 , 2000, The Journal of Immunology.
[87] L. Ballou,et al. The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. , 2000, Arthritis and rheumatism.
[88] J. Dayer,et al. Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis. , 2000, Cytokine.
[89] L. Joosten,et al. IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. , 2000, The Journal of clinical investigation.
[90] L. Joosten,et al. Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4. , 2000, Arthritis and rheumatism.
[91] J. Pelletier,et al. Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis. , 2000, Arthritis and rheumatism.
[92] O. Nadiv,et al. IL‐17 regulates gene expression and protein synthesis of the complement system, C3 and factor B, in skin fibroblasts , 2000, Clinical and experimental immunology.
[93] W. Maśliński,et al. High Levels of IL-17 in Rheumatoid Arthritis Patients: IL-15 Triggers In Vitro IL-17 Production Via Cyclosporin A-Sensitive Mechanism1 , 2000, The Journal of Immunology.
[94] H. Nagafuchi,et al. Characterization of Tissue Outgrowth Developed in vitro in Patients with Rheumatoid Arthritis: Involvement of T Cells in the Development of Tissue Outgrowth , 2000, International Archives of Allergy and Immunology.
[95] S. Fiorito,et al. Intracytoplasmic Th1 and Th2 cytokines in rheumatoid arthritis blood and synovial tissue. , 1999, Journal of autoimmunity.
[96] F. Breedveld,et al. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis. , 1999, Journal of immunology.
[97] H. Makino,et al. Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis. , 1999, Arthritis and rheumatism.
[98] T. Martin,et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. , 1999, The Journal of clinical investigation.
[99] P. Miossec,et al. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. , 1999, Arthritis and rheumatism.
[100] J. Quach,et al. Interleukin-17-induced Gene Expression in Articular Chondrocytes Is Associated with Activation of Mitogen-activated Protein Kinases and NF-κB* , 1998, The Journal of Biological Chemistry.
[101] P. Miossec,et al. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. , 1998, Journal of immunology.
[102] N. Udagawa,et al. Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. , 1998, Biochemical and biophysical research communications.
[103] D. Lacey,et al. Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.
[104] D. Bishop,et al. Alloantigen-reactive Th1 development in IL-12-deficient mice. , 1998, Journal of immunology.
[105] W. B. van den Berg,et al. Effect of interleukin 1 and leukaemia inhibitory factor on chondrocyte metabolism in articular cartilage from normal and interleukin-6-deficient mice: role of nitric oxide and IL-6 in the suppression of proteoglycan synthesis. , 1997, Cytokine.
[106] A. Billiau,et al. Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. , 1997, Journal of immunology.
[107] F. Breedveld,et al. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. , 1997, Arthritis and rheumatism.
[108] H. Nishiura,et al. IL-8/NAP-1 is the major T-cell chemoattractant in synovial tissues of rheumatoid arthritis. , 1996, Clinical immunology and immunopathology.
[109] N. Udagawa,et al. Interleukin‐6 and soluble interleukin‐6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast‐like cell formation , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[110] F. Finkelman,et al. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2 , 1994, The Journal of experimental medicine.
[111] L. Punzi,et al. Interrelationships between interleukin (IL)-1, IL-6 and IL-8 in synovial fluid of various arthropathies , 1994, Agents and Actions.
[112] H. Mcdevitt,et al. Heterogeneous effects of IFN-gamma in adjuvant arthritis. , 1989, Journal of immunology.
[113] O. Mellbye,et al. Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex. , 1986, Arthritis and rheumatism.
[114] Vlad I. Morariu,et al. Expression , 2015, Principles of Molecular Virology.
[115] K. Chiba. [A new orally active anti-rheumatic drug targets IL-15 and IL-17]. , 2007, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.
[116] S-Y Hwang,et al. Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-kappaB- and p38 MAPK-dependent signalling pathways. , 2007, Rheumatology.
[117] C. Brinckerhoff,et al. Matrix metalloproteinases: role in arthritis. , 2006, Frontiers in bioscience : a journal and virtual library.
[118] J. Peschon,et al. Requirement of local synovial IL-17 receptor signaling in the progression of chronic synovitis and bone erosion in arthritis , 2004 .
[119] P. Wooley,et al. IFNgamma deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vbeta6 and Vbeta8 in arthritic joints. , 2003, Annals of the rheumatic diseases.
[120] T. Martin,et al. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. , 2002, Bone.
[121] M. Feldmann,et al. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? , 2001, Annual review of immunology.
[122] T. Taniguchi,et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. , 2000, Nature.
[123] T. Martin,et al. Tumor Necrosis Factor (cid:97) Stimulates Osteoclast Differentiation by a Mechanism Independent of the ODF/RANKL–RANK Interaction , 2022 .